Kruis, W <br/><br/>
Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses.  [electronic resource] 

 -  Gut  Dec 2001 
 - 783-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0017-5749 
<br/><br/><label>Standard No.: </label>10.1136/gut.49.6.783  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminosalicylic Acids--administration & dosage<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Colitis, Ulcerative--drug therapy<br/>Colon--pathology<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Male<br/>Mesalamine--administration & dosage<br/>Phenylhydrazines<br/>Prodrugs--administration & dosage